Bio Protocol vs IKA — how do they compare? Bio Protocol trades at Rp432.61 (market cap Rp983,84M, Rp162,92M 24h volume), while IKA trades at Rp46.33 (market cap Rp139,42M, Rp4,78M 24h volume). The key difference: Bio Protocol is far larger — about 7.1× IKA's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while IKA's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and IKA for 3 Days on average.
| BIO | IKA | |
|---|---|---|
Market Cap | Rp983,84M | Rp139,42M |
Volume (24h) | Rp162,92M | Rp4,78M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 3B IKA |
Typical Hold Time | 18 Days | 3 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
IKA trades at Rp46.73 with a market cap of Rp141.55M, showing neutral technical signals across moving averages and oscillators. The token currently sits between support at Rp43 and resistance at Rp49, indicating consolidation. With a short average hold time of 3 days, traders appear to be taking quick positions rather than long-term holding. No recent protocol updates or ecosystem developments have been reported for this digital asset.
Overall outlook remains neutral with limited trading activity and minimal fundamental catalysts. Key opportunities include potential breakout above Rp49 resistance, while major risks include low liquidity and the token's small market cap making it vulnerable to volatility. Investors should monitor for any upcoming protocol developments or exchange listings that could drive momentum.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Ika is a decentralized network enabling secure, native cross-chain interoperability through advanced cryptography. It allows smart contracts to manage assets across multiple blockchains without relying on bridges or wrapped tokens. Using 2PC-MPC cryptography, Ika provides zero-trust asset control across chains like Bitcoin and Ethereum. Its dWallet primitive enables programmable, consent-based signing, and it is built on Sui for high-speed, scalable transactions.
Read more on IKA →